Search

Displaying results 8171 - 8180 of 9667 in total
  1. Drug

    Meluadrine

    go.drugbank.com/drugs/DB20693
    Experimental

    Meluadrine has a monoisotopic molecular weight of 243.1 Da.

  2. Drug

    Bamirastine

    go.drugbank.com/drugs/DB21186
    Experimental

    Bamirastine has a monoisotopic molecular weight of 527.29 Da.

  3. Drug

    Barmastine

    go.drugbank.com/drugs/DB21253
    Experimental

    Barmastine has a monoisotopic molecular weight of 483.24 Da.

  4. Drug

    Zanoterone

    go.drugbank.com/drugs/DB21384
    Experimental

    Zanoterone has a monoisotopic molecular weight of 416.21 Da.

  5. Drug

    N-Formylmethionine

    go.drugbank.com/drugs/DB04464
    Experimental

    The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells.

  6. Drug

    Pictilisib

    go.drugbank.com/drugs/DB11663
    Investigational

    Pictilisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Advanced Solid Tumours, Metastatic Breast Cancer, and Non-Hodgkin's Lymphoma, Solid Cancers, among others.

  7. Drug

    Vatreptacog alfa

    go.drugbank.com/drugs/DB12409
    Investigational

    Vatreptacog Alfa (Activated) has been used in trials studying the treatment of Haemophilia B, Haemophilia A, Congenital Bleeding Disorder, Haemophilia A With Inhibitors, and Haemophilia B With Inhibitors

  8. Drug

    5-fluoro-2'-deoxycytidine

    go.drugbank.com/drugs/DB12957
    Investigational

    5-fluoro-2'-deoxycytidine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, and Urinary Bladder Neoplasms, among others.

  9. Drug

    PCS-499

    go.drugbank.com/drugs/DB15122
    Investigational

    PCS-499 is under investigation in clinical trial NCT01487109 (A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients).

  10. Drug

    MBO7133

    go.drugbank.com/drugs/DB04999
    Experimental

    MB07133 is a HepDirect prodrug of an activated form of cytarabine (araC), an anti-cancer drug that is used to treat leukemia but is ineffective against primary liver cancer. AraC's anti-cancer activity is associated with its ability to b...